Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer
Authors:
Open Access
- 1 February 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (17) , 28176-28186
Abstract
Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancerKeywords
This publication has 45 references indexed in Scilit:
- The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancerOncotarget, 2015
- The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migrationOncotarget, 2015
- The striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivoNeurobiology of Aging, 2015
- Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistanceNature, 2014
- International Variations in Bladder Cancer Incidence and MortalityEuropean Urology, 2014
- Genome-wide screening and identification of long noncoding RNAs and their interaction with protein coding RNAs in bladder urothelial cell carcinomaCancer Letters, 2014
- Increased expression of long noncoding RNA ABHD11-AS1 in gastric cancer and its clinical significanceMedical Oncology, 2014
- Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentinHepatology, 2012
- Activity-based proteomics: Identification of ABHD11 and ESD activities as potential biomarkers for human lung adenocarcinomaJournal of Proteomics, 2011
- High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progressionBMC Cancer, 2009